Pulmonx Statistics

Total Valuation

Pulmonx has a market cap or net worth of $62.75 million. The enterprise value is $35.35 million.

Market Cap	62.75M
Enterprise Value	35.35M

Important Dates

The last earnings date was Wednesday, July 30, 2025, after market close.

Earnings Date	Jul 30, 2025
Ex-Dividend Date	n/a

Share Statistics

Pulmonx has 40.75 million shares outstanding. The number of shares has increased by 3.35% in one year.

Current Share Class	40.75M
Shares Outstanding	40.75M
Shares Change (YoY)	+3.35%
Shares Change (QoQ)	+1.19%
Owned by Insiders (%)	2.59%
Owned by Institutions (%)	84.35%
Float	39.69M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.68
Forward PS	0.62
PB Ratio	0.91
P/TBV Ratio	0.94
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	0.39
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.35, with a Debt / Equity ratio of 0.82.

Current Ratio	5.35
Quick Ratio	4.48
Debt / Equity	0.82
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-16.66

Financial Efficiency

Return on equity (ROE) is -66.88% and return on invested capital (ROIC) is -24.35%.

Return on Equity (ROE)	-66.88%
Return on Assets (ROA)	-21.57%
Return on Invested Capital (ROIC)	-24.35%
Return on Capital Employed (ROCE)	-44.25%
Revenue Per Employee	$311,165
Profits Per Employee	-$195,670
Employee Count	291
Asset Turnover	0.57
Inventory Turnover	1.47

Taxes

In the past 12 months, Pulmonx has paid $542,000 in taxes.

Income Tax	542,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -72.98% in the last 52 weeks. The beta is 0.43, so Pulmonx's price volatility has been lower than the market average.

Beta (5Y)	0.43
52-Week Price Change	-72.98%
50-Day Moving Average	2.68
200-Day Moving Average	5.27
Relative Strength Index (RSI)	28.67
Average Volume (20 Days)	978,520

Short Selling Information

The latest short interest is 1.37 million, so 3.36% of the outstanding shares have been sold short.

Short Interest	1.37M
Short Previous Month	1.44M
Short % of Shares Out	3.36%
Short % of Float	3.45%
Short Ratio (days to cover)	2.28

Income Statement

In the last 12 months, Pulmonx had revenue of $90.55 million and -$56.94 million in losses. Loss per share was -$1.43.

Revenue	90.55M
Gross Profit	66.16M
Operating Income	-55.20M
Pretax Income	-57.29M
Net Income	-56.94M
EBITDA	-53.95M
EBIT	-55.20M
Loss Per Share	-$1.43

Full Income Statement

Balance Sheet

The company has $84.23 million in cash and $56.83 million in debt, giving a net cash position of $27.40 million or $0.67 per share.

Cash & Cash Equivalents	84.23M
Total Debt	56.83M
Net Cash	27.40M
Net Cash Per Share	$0.67
Equity (Book Value)	69.09M
Book Value Per Share	1.70
Working Capital	97.57M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$31.10 million and capital expenditures -$877,000, giving a free cash flow of -$31.98 million.

Operating Cash Flow	-31.10M
Capital Expenditures	-877,000
Free Cash Flow	-31.98M
FCF Per Share	-$0.78

Full Cash Flow Statement

Margins

Gross margin is 73.07%, with operating and profit margins of -60.96% and -62.88%.

Gross Margin	73.07%
Operating Margin	-60.96%
Pretax Margin	-62.28%
Profit Margin	-62.88%
EBITDA Margin	-59.58%
EBIT Margin	-60.96%
FCF Margin	n/a

Dividends & Yields

Pulmonx does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.35%
Shareholder Yield	-3.35%
Earnings Yield	-90.74%
FCF Yield	-50.96%

Analyst Forecast

The average price target for Pulmonx is $7.66, which is 397.40% higher than the current price. The consensus rating is "Buy".

Price Target	$7.66
Price Target Difference	397.40%
Analyst Consensus	Buy
Analyst Count	7
Revenue Growth Forecast (5Y)	32.19%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Pulmonx has an Altman Z-Score of -2.67 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-2.67
Piotroski F-Score	3